Serologic Response to Messenger RNA Coronavirus Disease 2019 Vaccines in Inflammatory Bowel Disease Patients Receiving Biologic Therapies.

Serologic Response to Messenger RNA Coronavirus Disease 2019 Vaccines in Inflammatory Bowel Disease Patients Receiving Biologic Therapies.
复制标题

DOI：
10.1053/j.gastro.2021.04.025
复制
发表时间：
2021-08
期刊：
Gastroenterology
影响因子：
29.4
通讯作者：
ICARUS-IBD Working Group
ICARUS-IBD Working Group
中科院分区：
医学1区
文献类型：
--
作者：
Wong SY;Dixon R;Martinez Pazos V;Gnjatic S;Colombel JF;Cadwell K;ICARUS-IBD Working Group
来源链接：
https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8055494/

文献摘要

参考文献

被引文献

相似文献

""
Effect of IBD medications on COVID-19 outcomes: results from an international registry
DOI： 10.1136/gutjnl-2020-322539
发表时间： 2021-04-01
期刊： GUT
影响因子： 24.5
作者：
Ungaro, Ryan C.;Brenner, Erica J.;Kappelman, Michael D.
通讯作者： Kappelman, Michael D.
SARS-CoV-2 vaccination for patients with inflammatory bowel diseases: recommendations from an international consensus meeting.
DOI： 10.1136/gutjnl-2020-324000
发表时间： 2021-04
期刊： Gut
影响因子： 24.5
作者：
Siegel CA;Melmed GY;McGovern DP;Rai V;Krammer F;Rubin DT;Abreu MT;Dubinsky MC;International Organization for the Study of Inflammatory Bowel Disease (IOIBD);International Organization for the Study of Inflammatory Bowel Diseases (IOIBD)
通讯作者： International Organization for the Study of Inflammatory Bowel Diseases (IOIBD)
Anti-SARS-CoV-2 antibody responses are attenuated in patients with IBD treated with infliximab
DOI： 10.1136/gutjnl-2021-324388
发表时间： 2021-05-01
期刊： GUT
影响因子： 24.5
作者：
Kennedy, Nicholas A.;Goodhand, James R.;Ahmad, Tariq
通讯作者： Ahmad, Tariq
Corticosteroids, But Not TNF Antagonists, Are Associated With Adverse COVID-19 Outcomes in Patients With Inflammatory Bowel Diseases: Results From an International Registry
DOI： 10.1053/j.gastro.2020.05.032
发表时间： 2020-08-01
期刊： GASTROENTEROLOGY
影响因子： 29.4
作者：
Brenner, Erica J.;Ungaro, Ryan C.;Kappelman, Michael D.
通讯作者： Kappelman, Michael D.